The Emirates Drug Establishment (EDE) in UAE has announced a recall of infant formula products made by Nestlé after traces of Bacillus cereus bacteria were found in a raw material used in production.
The recall affects NAN Comfort 1, NAN OPTIPRO 1, NAN SUPREME PRO 1, 2, 3, S-26 Ultima 1, 2, 3, and Alfamino. The bacteria can produce the toxin cereulide.
The Emirates Drug Establishment said the recall is “voluntary and precautionary” and was initiated in coordination with Nestlé to protect consumer health and safety.
UAE recalls Nestlé baby formula over Bacillus cereus bacteria traces
The Establishment clarified that no illness or events linked to the affected batches have been reported or confirmed to date. All other Nestlé products remain safe for consumption.
The EDE said that “product safety and quality, particularly when it comes to children’s health, is the Establishment’s highest priority.”
The affected batches have been quarantined in the company’s and distributors’ warehouses, according to the Establishment. Efforts are ongoing to complete the recall of any remaining quantities in accordance with approved procedures.
EDE and Nestlé remove affected batches from market
The recall process is being conducted in coordination with authorities in the UAE to ensure the complete removal of the affected batches from all points of sale, including online retail platforms.
The Establishment said these measures were taken as part of its commitment to reinforcing the national pharmaceutical security system and ensuring the availability of medical products at the highest standards of quality and safety.
The EDE operates a framework that relies on proactive risk assessment and the monitoring of local and global pharmaceutical supply chains, enhancing the country’s ability to respond to any incident that may impact the availability or safety of medical products.
